M. Bagot

Also affiliated with Université Paris Cité, Saint Louis University Hospital, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Institut Cochin, Hôpital Saint-Louis, Medizinische Hochschule Brandenburg Theodor Fontane, Institut de recherche Saint-Louis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*”.

Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*

British Journal of Dermatology(2020)10.1111/bjd.19252

N/A

0DataRank · unranked

87 citations

H. Miles Prince, Richard Cowan, Maarten H. Vermeer, Evangelia Papadavid, M. Bagot +62 more

Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.09.003

N/A

0DataRank · unranked

34 citations

Stacie Hudgens, Sarah McCue Horwitz, Pietro Quaglino, Richard Cowan, Larisa J. Geskin +14 more

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Dermatology and Therapy(2021)10.1007/s13555-021-00624-7

N/A

0DataRank · unranked

44 citations

Kerri E. Rieger, M. Bagot, Jennifer Choi, David C. Fisher, Joan Guitart +11 more